DR will not be able to sell weight loss drugs in India Reddy’s and Onesource, Delhi High Court banned due to patent dispute – Delhi High Court Bars Domestic Sale of Semaglutide by Dr Reddys and Overce over Patent Dispute
Semaglutide patent dispute: The Delhi High Court has issued an important interim order in the patent dispute related to Denmark’s drug company Novo Nordisk’s famous anti-dibitic and anti-options semaglutide. Court did Dr. Reddy’s Laboratories and Onesource Specialty Pharma have been stopped from sales and marketing of this drug in India. However, they are allowed to…
